The COVID-19 pandemic, as an official global health emergency, ended in May 2023 when the World Health Organization lifted its Public Health Emergency of International Concern declaration. But the virus itself never went away. SARS-CoV-2 continues to circulate, mutate, hospitalize people, and kill, just at far lower and more predictable levels than during the crisis years of 2020 through 2022. The short answer: the pandemic phase is over, but COVID-19 is now a permanent part of the infectious disease landscape.
What “Pandemic Over” Actually Means
The word “pandemic” describes a pattern of spread, not a virus. A pandemic happens when a new pathogen spreads rapidly across multiple countries and continents, overwhelming the level of immunity in the population. The key measurement is something epidemiologists call the effective reproductive number: how many people, on average, each infected person passes the virus to. During a pandemic, that number stays well above one, meaning cases multiply exponentially.
When a virus transitions to what scientists call endemicity, that number settles to roughly one on average. The virus doesn’t disappear. Instead, it reaches a dynamic equilibrium where new infections are balanced by the immunity people have built through vaccination, prior infection, or both. New susceptible people enter the picture through births, immigration, and the gradual fading of immunity over time, which keeps the virus circulating at a relatively stable, lower level. That’s where COVID-19 sits now.
How Much COVID Is Circulating Today
The most reliable real-time indicator of community spread in the United States is wastewater surveillance. The CDC monitors viral particles in sewage systems nationwide, which captures infections whether or not people get tested. As of early April 2026, COVID-19 wastewater viral activity was classified as “very low,” with a score of 1.29 on the CDC’s scale. For comparison, influenza A registered even lower at 1.00, and RSV was slightly higher at 2.61 but still in the “low” range. COVID-19 is, at this point, behaving like other seasonal respiratory viruses.
Globally, the WHO reported 2,940 new COVID-19 hospitalizations across 32 countries and 1,254 deaths across 37 countries during a recent 28-day period ending in mid-March 2026. Those numbers are a fraction of what the world saw during the Delta and Omicron waves, when daily death tolls regularly exceeded 10,000. The virus is still dangerous, particularly for older adults and people with weakened immune systems, but it is no longer overwhelming hospitals on a global scale.
The Virus Keeps Changing
SARS-CoV-2 continues to evolve, and the WHO tracks several variants under monitoring. The currently watched lineages include KP.3.1.1 (first documented in March 2024), NB.1.8.1 (January 2025), XFG (January 2025), and BA.3.2 (November 2024). None of these has triggered the kind of explosive, immune-evading wave that Omicron caused in late 2021 and early 2022. The mutations keep coming, but population-level immunity from years of exposure and vaccination has made each new variant less disruptive overall.
This ongoing evolution is exactly what scientists expected from a virus settling into endemicity. Like influenza, SARS-CoV-2 will likely produce seasonal surges and require updated vaccines to match the dominant strains. The CDC’s 2025-2026 vaccination guidance recommends one updated dose for most people ages 5 and older, with two doses for adults 65 and older and for young children who haven’t been vaccinated before. The approach mirrors the annual flu shot model, reflecting the shift from emergency response to routine public health management.
Long COVID Remains a Concern
Even as acute infections have become milder for most people, long COVID continues to affect a significant number of those who were infected during or after the pandemic’s peak. A large U.S. study tracking adults with long COVID found that among those who met the threshold for long COVID at three months after infection, only 19% showed meaningful improvement over the following year. That means the majority of people with persistent symptoms, including fatigue, cognitive difficulties, and shortness of breath, are dealing with a condition that can last well beyond a year.
This is one of the clearest ways the pandemic’s effects linger even after the emergency phase has ended. Millions of people worldwide are living with a chronic condition that didn’t exist before 2020, and recovery for many is slow and uncertain.
What This Means for You
If you’re wondering whether you still need to think about COVID-19, the answer is yes, but not the way you did in 2020. The practical reality looks more like how you’d approach flu season. Getting an updated vaccine each year reduces your risk of severe illness. If you develop symptoms, rapid antigen tests can confirm infection, though they work best when your viral load is high. Studies have shown these tests catch about 91% of infections when viral levels are at their peak, but sensitivity drops significantly as the infection progresses or if you test too early.
The pandemic as a global crisis, with lockdowns, overwhelmed ICUs, and emergency declarations, is over. COVID-19 as a disease is not. It has joined the roster of respiratory infections that circulate year-round, spike seasonally, and pose the greatest risk to the elderly and immunocompromised. The difference between 2020 and now is that most people carry enough immunity to fight the virus off without serious illness, and the healthcare system is no longer buckling under the weight of cases. That’s the messy, undramatic reality of how pandemics end: not with the virus vanishing, but with the world learning to absorb its presence.